Print
Email
Print Edition Stories
Burlington-based orthopedic implants developer ConforMIS Inc. has secured a $1.4 million loan from MassDevelopment’s Emerging Technology Fund to grow its supply chain and manufacturing capabilities.
The company develops customized knee implant systems using computed tomography scans and CAD software. In February, ConforMIS got 510k clearance from the U.S. Food and Drug Administration to market its iTotal CR Knee Replacement System.
The MassDevelopment loan will pay for more fabrication equipment and instruments for ConforMIS.
“The Emerging Technology Fund helps companies that are starting or expanding manufacturing in Massachusetts, and this project is a triple play: boosting production, creating jobs, and serving the health needs of the Commonwealth,” MassDevelopment President and CEO Marty Jones said in a news release today.
Privately held ConforMIS is led by CEO Philipp Lang, who founded the company in 2004.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
